BIOB insider filings

BIO-RAD LABORATORIES, INC. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2025-04-25. Screen BIOB transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for BIOB between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — BIO-RAD LABORATORIES, INC.

FiledFormInsiderReported transactionsSource
2025-04-254Lakkaraju Roop Kalyan — EVP, Chief Financial OfficerOption exercise (M): 1,077 @ $0 · Tax withholding (F): 386 @ $249.74 · Option exercise (M): 1,077 (derivative) @ $0EDGAR
2025-04-254ENLOE COURTNEY C — EVP, General Counsel & SecOption exercise (M): 186 @ $0 · Tax withholding (F): 67 @ $249.74 · Option exercise (M): 186 (derivative) @ $0EDGAR
2024-10-254DiVincenzo Jonathan P. — President & COOGrant/award (A): 7,478 (derivative) @ $0EDGAR
2024-10-224EVRAN SEDAT — EVP, Global Supply ChainOption exercise (M): 1,044 @ $0 · Tax withholding (F): 335 @ $346.37 · Option exercise (M): 1,044 (derivative) @ $0EDGAR
2024-09-104ENGELHARDT EVA ANETTE — EVP, President, CDGGrant/award (A): 4,608 (derivative) @ $0EDGAR
2024-09-104ENLOE COURTNEY C — EVP, General Counsel & SecGrant/award (A): 3,072 (derivative) @ $0EDGAR
2024-09-104Lakkaraju Roop Kalyan — EVP, Chief Financial OfficerGrant/award (A): 6,143 (derivative) @ $0EDGAR
2024-09-104EVRAN SEDAT — EVP, Global Supply ChainGrant/award (A): 3,456 (derivative) @ $0EDGAR
2024-09-104SCHWARTZ NORMAN D — Chairman & CEO, Director, 10% ownerGrant/award (A): 13,822 (derivative) @ $0EDGAR
2024-09-104Last Andrew J. — EVP, Chief Operating OfficerOption exercise (M): 3,000 @ $299.24 · Sale (S): 3,000 @ $329.94 · Option exercise (M): 3,000 (derivative) @ $0EDGAR
2024-09-104Allison Schwartz — DirectorGrant/award (A): 369 (derivative) @ $0EDGAR
2024-09-104COREY COLLEEN — EVP, Global Human ResourcesGrant/award (A): 2,304 (derivative) @ $0EDGAR
2024-09-104BARRY JAMES — EVP, President, LSGGrant/award (A): 4,224 (derivative) @ $0EDGAR
2024-09-104Crowley Michael — EVP, GBL Commercial OperationsGrant/award (A): 3,456 (derivative) @ $0EDGAR
2024-09-104HINCKLEY GREGORY K — DirectorGrant/award (A): 308 (derivative) @ $0EDGAR
2024-09-104PINKSTON ARNOLD A — DirectorGrant/award (A): 308 (derivative) @ $0EDGAR
2024-09-104PEI MELINDA LITHERLAND — DirectorGrant/award (A): 308 (derivative) @ $0EDGAR
2024-09-104EDWARDS JEFFREY L — DirectorGrant/award (A): 308 (derivative) @ $0EDGAR
2024-09-054Crowley Michael — EVP, GBL Commercial OperationsOption exercise (M): 751 @ $0 · Tax withholding (F): 268 @ $337.32 · Option exercise (M): 520 @ $0 · Tax withholding (F): 218 @ $337.32 · Option exercise (M): 405 @ $0 · Tax withholding (F): 145 @ $337.32 · +9 moreEDGAR
2024-09-044SCHWARTZ NORMAN D — Chairman, President, and CEO, Director, 10% ownerOption exercise (M): 3,005 @ $0 · Tax withholding (F): 1,607 @ $337.32 · Option exercise (M): 2,081 @ $0 · Tax withholding (F): 801 @ $337.32 · Option exercise (M): 1,266 @ $0 · Tax withholding (F): 545 @ $337.32 · +9 moreEDGAR
2024-09-044BARRY JAMES — EVP, President, LSGOption exercise (M): 250 @ $0 · Tax withholding (F): 90 @ $337.32 · Option exercise (M): 173 @ $0 · Tax withholding (F): 62 @ $337.32 · Option exercise (M): 177 @ $0 · Tax withholding (F): 64 @ $337.32 · +10 moreEDGAR
2024-09-044COREY COLLEEN — EVP, Global Human ResourcesOption exercise (M): 500 @ $0 · Tax withholding (F): 179 @ $337.32 · Option exercise (M): 347 @ $0 · Tax withholding (F): 124 @ $337.32 · Option exercise (M): 253 @ $0 · Tax withholding (F): 91 @ $337.32 · +9 moreEDGAR
2024-09-044Allison Schwartz — DirectorOption exercise (M): 74 @ $0 · Tax withholding (F): 35 @ $337.32 · Option exercise (M): 42 @ $0 · Tax withholding (F): 20 @ $337.32 · Option exercise (M): 31 @ $0 · Tax withholding (F): 15 @ $337.32 · +9 moreEDGAR
2024-09-044Last Andrew J. — EVP, Chief Operating OfficerOption exercise (M): 1,252 @ $0 · Tax withholding (F): 635 @ $337.32 · Option exercise (M): 867 @ $0 · Tax withholding (F): 440 @ $337.32 · Option exercise (M): 633 @ $0 · Tax withholding (F): 321 @ $337.32 · +6 moreEDGAR
2024-08-284Allison Schwartz — DirectorGift (G): 57 @ $0EDGAR
2024-08-284SCHWARTZ STEVEN D — 10% ownerGift (G): 57 @ $0 · Gift (G): 57 @ $0EDGAR
2024-08-284SCHWARTZ NORMAN D — Chairman, President, and CEO, Director, 10% ownerGift (G): 57 @ $0 · Gift (G): 57 @ $0EDGAR
2024-08-284SCHWARTZ ALICE N — 10% ownerGift (G): 3,190 @ $0 · Gift (G): 342 @ $0EDGAR
2024-07-294ENGELHARDT EVA ANETTE — EVP, President, CDGGrant/award (A): 983 (derivative) @ $0EDGAR
2024-06-144Crowley Michael — EVP, GBL Commercial OperationsSale (S): 369 @ $281.91EDGAR
2024-05-014SCHWARTZ STEVEN D — 10% ownerSale (S): 320 @ $463.86EDGAR
2024-04-304Last Andrew J. — EVP, Chief Operating OfficerOption exercise (M): 1,000 @ $0 · Tax withholding (F): 357 @ $277.11 · Option exercise (M): 1,000 (derivative) @ $0EDGAR
2024-04-294Lakkaraju Roop Kalyan — EVP, Chief Financial OfficerGrant/award (A): 4,311 (derivative) @ $0EDGAR
2024-03-124ERNST TIMOTHY S — EVP, General Counsel & SecGrant/award (A): 2,357 (derivative) @ $0EDGAR
2024-03-124Last Andrew J. — EVP, Chief Operating OfficerGrant/award (A): 5,891 (derivative) @ $0EDGAR
2024-03-124MAY SIMON — EVP, President, LSGGrant/award (A): 3,535 (derivative) @ $0EDGAR
2024-03-124COREY COLLEEN — EVP, Global Human ResourcesGrant/award (A): 2,357 (derivative) @ $0EDGAR
2024-03-124EVRAN SEDAT — EVP, Global Supply ChainGrant/award (A): 3,535 (derivative) @ $0EDGAR
2024-03-124SCHWARTZ NORMAN D — Chairman, President, and CEO, Director, 10% ownerGrant/award (A): 14,137 (derivative) @ $0EDGAR
2024-03-124Crowley Michael — EVP, GBL Commercial OperationsGrant/award (A): 3,535 (derivative) @ $0EDGAR
2024-02-294ERNST TIMOTHY S — EVP, General Counsel & SecOption exercise (M): 2,500 @ $326.15 · Sale (S): 2,500 @ $330.55 · Option exercise (M): 2,500 (derivative) @ $0EDGAR
2024-02-284Crowley Michael — EVP, GBL Commercial OperationsOption exercise (M): 3,000 @ $215.98 · Sale (S): 3,000 @ $336 · Option exercise (M): 3,000 (derivative) @ $0EDGAR
2023-12-194WRIGHT DARA — EVP, President, CDGOption exercise (M): 502 @ $0 · Tax withholding (F): 174 @ $306.12 · Option exercise (M): 502 (derivative) @ $0EDGAR
2023-12-144SCHWARTZ STEVEN D — 10% ownerGift (G): 49 @ $0 · Gift (G): 49 @ $0EDGAR
2023-12-124WRIGHT DARA — EVP, President, CDGSale (S): 1,200 @ $299.16EDGAR
2023-12-084Allison Schwartz — DirectorGift (G): 49 @ $0EDGAR
2023-12-074SCHWARTZ NORMAN D — Chairman, President, and CEO, Director, 10% ownerGift (G): 49 @ $0 · Gift (G): 49 @ $0EDGAR
2023-12-074SCHWARTZ ALICE N — 10% ownerGift (G): 3,270 @ $0 · Gift (G): 294 @ $0EDGAR
2023-11-284Crowley Michael — EVP, GBL Commercial OperationsSale (S): 642 @ $305.10EDGAR
2023-11-024SCHWARTZ NORMAN D — Chairman, President, and CEO, Director, 10% ownerOption exercise (M): 35,000 @ $119.80 · Tax withholding (F): 25,642 @ $273 · Option exercise (M): 16,000 @ $139.56 · Tax withholding (F): 12,274 @ $273 · Option exercise (M): 15,000 @ $159.32 · Tax withholding (F): 12,024 @ $273 · +3 moreEDGAR

Recent 8-K events — BIO-RAD LABORATORIES, INC.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-048-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-048-K2.02 — Results of Operations and Financial Condition
?
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-308-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-248-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2026-02-198-K7.01 — Regulation FD DisclosureEDGAR
2026-02-128-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2025-10-298-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2025-09-308-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2025-08-268-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2025-07-318-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=BIOB returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs